Nuvox Therapeutics
Business Services · Arizona, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6363 N Swan Rd Ste 151, Tucson, Arizona,...Website
www.nuvoxtherapeutics.comRevenue
<$5 MillionIndustry
About Nuvox Therapeutics
Nuvox Therapeutics Org Chart
Is Nuvox Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Nuvox Therapeutics recently announced quarterly report
Product Launch: Get notified when Nuvox Therapeutics launches new products
Nuvox Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Nuvox Therapeutics
Funding: Get notified immidiatlly once Nuvox Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Nuvox Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Nuvox Therapeutics is spiking on competitors!
Click to see if Nuvox Therapeutics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Nuvox Therapeutics as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Nuvox Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nuvox Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nuvox Therapeutics.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nuvox Therapeutics
NuvOx Therapeutics is a clinical-stage biopharmaceutical company developing NanO2, an oxygen therapeutic for hypoxia-driven diseases. Administered intravenously, NanO2's nano-sized dodecafluoropentane droplets deliver oxygen to tissue. Focus areas include acute ischemic stroke, glioblastoma (GBM), and ARDS, with Phase IIb trials ongoing. FDA grante... Read More
